Skip to main content
Premium Trial:

Request an Annual Quote

Squibb Licenses Genome Therapeutics' Microbial Sequence Database

Premium

PRINCETON, NJ--Bristol-Myers Squibb here has signed a licensing agreement with Waltham, Mass., based Genome Therapeutics that gives the pharmaceutical giant access to the proprietary Patho Genome microbial sequence database. The alliance will expand Squibb's initiatives in applied genomics.

Squibb will gain nonexclusive access to the PathoGenome information in exchange for annual subscription fees, milestone payments, and royalty payments on any small molecules developed as a result of the partnership. Genome Therapeutics retains rights associated with the therapeutic, diagnostic, and vaccine use of bacterial genes or gene products.

"This alliance will significantly enhance our internal efforts in the important area of infectious diseases," observed Peter Ringrose, president of Squibb's Pharmaceu tical Research Institute. Robert Hennessey, Genome Therapeutics' president, chairman, and CEO, added, "Bristol-Myers Squibb has taken aggressive steps to incorporate human genomic sequence information into its research programs. We consider this agreement, in the pathogen arena, a significant validation of the comprehensive microbial genomic information available in our PathoGenome database." PathoGenome uses proprietary bioinformatics software to create a research tool that offers sequence information from both public-domain sources and from Genome Therapeutics' own research.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.